<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01210729</url>
  </required_header>
  <id_info>
    <org_study_id>ReFlow01</org_study_id>
    <nct_id>NCT01210729</nct_id>
  </id_info>
  <brief_title>Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke</brief_title>
  <acronym>ReFlow</acronym>
  <official_title>Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke (ReFlow Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saarland University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saarland University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to collect data on the use of the SOLITAIR FR device for
      treatment of acute ischemic stroke with large artery occlusion i.e. to investigate, whether
      the application of SOLITAIR is a safe and feasible method for interventional recanalization
      of large vessels with favorable patient outcome in acute stroke therapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall frequency of favourable clinical outcome (modified Rankin Scale 0 to 2), and unfavourable clinical outcome or death (modified Rankin Scale 3 to 6)</measure>
    <time_frame>Day 90</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial recanalization of occluded target vessel measured by Thrombolysis in Cerebral Infarction (TICI)score of 2b or 3 following the use of the SOLITAIRE FR Device</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Excellent functional clinical outcome (modified Rankin Scale 0 or 1)</measure>
    <time_frame>Day 90</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All causes of mortality</measure>
    <time_frame>Day 90</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with rapid neurological improvement (more than 4 points on the NIHSS) during the first 24 hours after treatment.</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptomatic intracranial haemorrhages up to 24 hours after treatment defined as homogeneous areas of haemorrhage, with or without mass effect or intraventricular extension with neurological deterioration</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time between arterial puncture and Flow Restoration</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time between arterial puncture and TICI 2b or 3 recanalization</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of SOLITAIRE device runs until recanalization</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with and degree of stenosis in the treated artery 90 days after recanalization with SOLITAIRE</measure>
    <time_frame>Day 90</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients in which thrombus material was preserved</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histological examination of the thrombus material in correlation with TICI 2b or 3 recanalization and favorable clinical outcome</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall frequency of modified Rankin Scale 0 to 2 at 30 days</measure>
    <time_frame>Day 30</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Acute Stroke</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Solitaire FR, ev3</intervention_name>
    <description>Placement of the stent in the occluded vessel segment, withdrawal in its unfolded state.</description>
    <other_name>device used: Solitaire FR, ev3, USA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-85 years

          -  Acute ischemic stroke with occlusion if ICA, MCA, VA or BA (TICI 0 or 1 flow) within
             the first 6 hours

        Exclusion Criteria:

          -  Rapidly improving neurological signs

          -  NHISS&gt;30 or coma

          -  Female patients, who are pregnant or lactating

          -  Use of warfarin anticoagulation with INR &gt; 1.5

          -  Platelet count &lt; 30,000

          -  Glucose &lt; 50 mg/dL

          -  Life expectancy of less than 90 days

          -  Computed tomography (CT) or Magnetic Resonance Imaging (MRI) evidence of hemorrhage on
             presentation

          -  CT showing hypodensity on presentation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wolfgang Reith, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saarland University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of diagnostic and interventional Neuroradiology</name>
      <address>
        <city>Homburg</city>
        <state>Saarland</state>
        <zip>66424</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Papanagiotou P, Roth C, Walter S, Behnke S, Politi M, Fassbender K, Haass A, Reith W. Treatment of acute cerebral artery occlusion with a fully recoverable intracranial stent: a new technique. Circulation. 2010 Jun 15;121(23):2605-6. doi: 10.1161/CIRCULATIONAHA.110.948166.</citation>
    <PMID>20547941</PMID>
  </reference>
  <reference>
    <citation>Roth C, Papanagiotou P, Behnke S, Walter S, Haass A, Becker C, Fassbender K, Politi M, Körner H, Romann MS, Reith W. Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke. 2010 Nov;41(11):2559-67. doi: 10.1161/STROKEAHA.110.592071. Epub 2010 Oct 14.</citation>
    <PMID>20947848</PMID>
  </reference>
  <reference>
    <citation>Papanagiotou P, Roth C, Walter S, Behnke S, Grunwald IQ, Viera J, Politi M, Körner H, Kostopoulos P, Haass A, Fassbender K, Reith W. Carotid artery stenting in acute stroke. J Am Coll Cardiol. 2011 Nov 29;58(23):2363-9. doi: 10.1016/j.jacc.2011.08.044.</citation>
    <PMID>22115640</PMID>
  </reference>
  <reference>
    <citation>Papanagiotou P, Roth C, Reith W. Letter by Papanagiotou et Al regarding article, &quot;percutaneous vascular interventions for acute ischemic stroke&quot;. Stroke. 2011 Sep;42(9):e545; author reply e546. doi: 10.1161/STROKEAHA.111.620989. Epub 2011 Jul 14.</citation>
    <PMID>21757666</PMID>
  </reference>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 27, 2010</study_first_submitted>
  <study_first_submitted_qc>September 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2010</study_first_posted>
  <last_update_submitted>December 1, 2011</last_update_submitted>
  <last_update_submitted_qc>December 1, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2011</last_update_posted>
  <responsible_party>
    <name_title>Prof. Wolfgang Reith</name_title>
    <organization>Department of diagnostic and interventional Neuroradiology, Saarland University Hospital</organization>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>mechanical recanalization</keyword>
  <keyword>self-expanding stent</keyword>
  <keyword>Solitaire</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

